Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125867861 | 12586786 | 1 | I | 20160721 | 0 | 20160722 | 20160722 | DIR | 68.00 | YR | F | N | 45.91000 | KG | 20160721 | N | PH | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125867861 | 12586786 | 1 | PS | MYCOPHENOLIC ACID. | MYCOPHENOLIC ACID | 1 | Oral | 0 | 720 | MG | BID | ||||||||
| 125867861 | 12586786 | 3 | C | TACROLIMUS. | TACROLIMUS | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 5 | C | DAPSONE. | DAPSONE | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 7 | C | CLOTRIMAZOLE TROCHE | CLOTRIMAZOLE | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 8 | SS | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 10 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 12 | C | COLACE CLEAR | DOCUSATE SODIUM | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 14 | C | COREG | CARVEDILOL | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 16 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 17 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 18 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 20 | C | OXYCODONE | OXYCODONE | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 22 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 23 | SS | TRICOR | FENOFIBRATE | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 25 | C | GENTAMICIN SULFATE. | GENTAMICIN SULFATE | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 27 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 29 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 31 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 125867861 | 12586786 | 33 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125867861 | 12586786 | 1 | Renal transplant |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125867861 | 12586786 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125867861 | 12586786 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 125867861 | 12586786 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125867861 | 12586786 | 1 | 20160418 | 20160721 | 0 |